NEW YORK ─ Epigenomics on Wednesday reported preliminary revenues of €200,000 ($216,000), down 33 percent from €300,000 in Q1 2019.
The firm said that its net loss for Q1 2020 narrowed slightly year over year to €2.9 million from €3.0 million.
NEW YORK ─ Epigenomics on Wednesday reported preliminary revenues of €200,000 ($216,000), down 33 percent from €300,000 in Q1 2019.
The firm said that its net loss for Q1 2020 narrowed slightly year over year to €2.9 million from €3.0 million.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.